192 related articles for article (PubMed ID: 19324442)
21. Health-related quality-of-life outcomes following IMRT versus conventional radiotherapy for oropharyngeal squamous cell carcinoma.
Yao M; Karnell LH; Funk GF; Lu H; Dornfeld K; Buatti JM
Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1354-60. PubMed ID: 17689885
[TBL] [Abstract][Full Text] [Related]
22. Chemoradiation and brachytherapy in biliary tract carcinoma: long-term results.
Deodato F; Clemente G; Mattiucci GC; Macchia G; Costamagna G; Giuliante F; Smaniotto D; Luzi S; Valentini V; Mutignani M; Nuzzo G; Cellini N; Morganti AG
Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):483-8. PubMed ID: 16242254
[TBL] [Abstract][Full Text] [Related]
23. Prospective trial of accelerated partial breast intensity-modulated radiotherapy.
Leonard C; Carter D; Kercher J; Howell K; Henkenberns P; Tallhamer M; Cornish P; Hunter K; Kondrat J
Int J Radiat Oncol Biol Phys; 2007 Apr; 67(5):1291-8. PubMed ID: 17234359
[TBL] [Abstract][Full Text] [Related]
24. Nasopharyngeal carcinoma treated with reduced-volume intensity-modulated radiation therapy: report on the 3-year outcome of a prospective series.
Lin S; Pan J; Han L; Zhang X; Liao X; Lu JJ
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1071-8. PubMed ID: 19362784
[TBL] [Abstract][Full Text] [Related]
25. [Improved treatment results in advanced gallbladder and bile duct cancer by postoperative combined radiotherapy].
Jörling P; Schmid HU; Leber K; Haubold B; Junghanns K
Leber Magen Darm; 1992 May; 22(3):116-9. PubMed ID: 1625509
[TBL] [Abstract][Full Text] [Related]
26. Acute toxicity of whole-pelvis IMRT in 87 patients with localized prostate cancer.
Sanguineti G; Endres EJ; Parker BC; Bicquart C; Little M; Chen G; Berilgen J
Acta Oncol; 2008; 47(2):301-10. PubMed ID: 18210303
[TBL] [Abstract][Full Text] [Related]
27. Intensity modulated radiation therapy for primary soft tissue sarcoma of the extremity: preliminary results.
Alektiar KM; Hong L; Brennan MF; Della-Biancia C; Singer S
Int J Radiat Oncol Biol Phys; 2007 Jun; 68(2):458-64. PubMed ID: 17363186
[TBL] [Abstract][Full Text] [Related]
28. Radiotherapy and razoxane in advanced bile duct carcinomas.
Rhomberg W; Stephan H; Böhler F; Erhart K; Eiter H
Anticancer Res; 2005; 25(5):3613-8. PubMed ID: 16101189
[TBL] [Abstract][Full Text] [Related]
29. Image-guided intensity-modulated photon radiotherapy using multifractionated regimen to paraspinal chordomas and rare sarcomas.
Terezakis SA; Lovelock DM; Bilsky MH; Hunt MA; Zatcky J; Yamada Y
Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1502-8. PubMed ID: 17689028
[TBL] [Abstract][Full Text] [Related]
30. Aichi cancer center initial experience of intensity modulated radiation therapy for nasopharyngeal cancer using helical tomotherapy.
Kodaira T; Tomita N; Tachibana H; Nakamura T; Nakahara R; Inokuchi H; Fuwa N
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1129-34. PubMed ID: 18922651
[TBL] [Abstract][Full Text] [Related]
31. Intensity-modulated radiotherapy for cervical lymph node metastases from unknown primary cancer.
Madani I; Vakaet L; Bonte K; Boterberg T; De Neve W
Int J Radiat Oncol Biol Phys; 2008 Jul; 71(4):1158-66. PubMed ID: 18258383
[TBL] [Abstract][Full Text] [Related]
32. Carcinomas of the paranasal sinuses and nasal cavity treated with radiotherapy at a single institution over five decades: are we making improvement?
Chen AM; Daly ME; Bucci MK; Xia P; Akazawa C; Quivey JM; Weinberg V; Garcia J; Lee NY; Kaplan MJ; El-Sayed I; Eisele DW; Fu KK; Phillips TL
Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):141-7. PubMed ID: 17459609
[TBL] [Abstract][Full Text] [Related]
33. Image-guided intensity-modulated radiation therapy for gallbladder carcinoma.
Fuller CD; Thomas CR; Wong A; Cavanaugh SX; Salter BJ; Herman TS; Fuss M
Radiother Oncol; 2006 Oct; 81(1):65-72. PubMed ID: 16971012
[TBL] [Abstract][Full Text] [Related]
34. Hypofractionated intensity-modulated radiotherapy for carcinoma of the prostate: analysis of toxicity.
Coote JH; Wylie JP; Cowan RA; Logue JP; Swindell R; Livsey JE
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1121-7. PubMed ID: 19131179
[TBL] [Abstract][Full Text] [Related]
35. Large cohort dose-volume response analysis of parotid gland function after radiotherapy: intensity-modulated versus conventional radiotherapy.
Dijkema T; Terhaard CH; Roesink JM; Braam PM; van Gils CH; Moerland MA; Raaijmakers CP
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1101-9. PubMed ID: 18472355
[TBL] [Abstract][Full Text] [Related]
36. Urinary toxicity after high dose intensity modulated radiotherapy as primary therapy for prostate cancer.
Fonteyne V; Villeirs G; Lumen N; De Meerleer G
Radiother Oncol; 2009 Jul; 92(1):42-7. PubMed ID: 19356817
[TBL] [Abstract][Full Text] [Related]
37. Intensity-modulated radiotherapy for pituitary adenomas: the preliminary report of the Cleveland Clinic experience.
Mackley HB; Reddy CA; Lee SY; Harnisch GA; Mayberg MR; Hamrahian AH; Suh JH
Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):232-9. PubMed ID: 17084541
[TBL] [Abstract][Full Text] [Related]
38. Tomotherapy for prostate adenocarcinoma: a report on acute toxicity.
Keiler L; Dobbins D; Kulasekere R; Einstein D
Radiother Oncol; 2007 Aug; 84(2):171-6. PubMed ID: 17692975
[TBL] [Abstract][Full Text] [Related]
39. Phase I-II studies on accelerated IMRT in breast carcinoma: technical comparison and acute toxicity in 332 patients.
Morganti AG; Cilla S; Valentini V; Digesu' C; Macchia G; Deodato F; Ferrandina G; Cece MG; Cirocco M; Garganese G; Di Lullo L; Traficante D; Scarabeo F; Panunzi S; De Gaetano A; Sallustio G; Cellini N; Sofo L; Piermattei A; Scambia G
Radiother Oncol; 2009 Jan; 90(1):86-92. PubMed ID: 19010560
[TBL] [Abstract][Full Text] [Related]
40. Intensity modulated radiation-therapy for preoperative posterior abdominal wall irradiation of retroperitoneal liposarcomas.
Bossi A; De Wever I; Van Limbergen E; Vanstraelen B
Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):164-70. PubMed ID: 17084556
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]